Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Fall;7(4):149-56.

Chemistry, metabolism, and toxicology of cannabis: clinical implications

Priyamvada Sharma  1 , Pratima Murthy, M M Srinivas Bharath
Affiliations

Chemistry, metabolism, and toxicology of cannabis: clinical implications

Priyamvada Sharma et al. Iran J Psychiatry. 2012 Fall.

Abstract

Cannabis is one of the most widely abused substances throughout the world. The primary psychoactive constituent of cannabis, delta 9-tetrahydrocannabinol (▵(9_)THC), produces a myriad of pharmacological effects in animals and humans. Although it is used as a recreational drug, it can potentially lead to dependence and behavioral disturbances and its heavy use may increase the risk for psychotic disorders.Many studies that endeavor to understand the mechanism of action of cannabis concentrate on pharmacokinetics and pharmacodynamics of cannabinoids in humans. However, there is limited research on the chronic adverse effects and retention of cannabinoids in human subjects.Cannabis can be detected in body fluids following exposure through active/passive inhalation and exposure through breastfeeding. Cannabis detection is directly dependent on accurate analytical procedures for detection of metabolites and verification of recent use.In this review, an attempt has been made to summarize the properties of cannabis and its derivatives, and to discuss the implications of its use with emphasis on bioavailability, limit of detection, carry over period and passive inhalation, important factors for detection and diagnosis.

Keywords: Cannabinoids; Cannabis; Mental disorders; Tetrahydrocannabinol.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Chemical Components of Cannabis
Figure 2
Figure 2
Metabolic route of ▵9-tetrahydrocannabinol (▵9_THC), its primary active metabolite 11-hydroxy-▵9-tetrahydrocannabinol (11-OH-THC) and the primary inactive metabolite, 11-nor-9-carboxy-▵ 9-tetrahydrocannabinol(THC-COOH) 12
See this image and copyright information in PMC

References

    1. Brecher EM. The Consumers Union Report - Licit and Illicit Drugs. Little, Brown & Co; 1972.
    1. Balabanova S, Parsche F, Pirsig W. First identification of drugs in Egyptian mummies. Naturwissenschaften. 1992;79:358. - PubMed
    1. Grotenhermen F. The toxicology of cannabis and cannabis prohibition. Chem Bio divers. 2007;4:1744–1769. - PubMed
    1. Raharjo TJ, Verpoorte R. Methods for the analysis of cannabinoids in biological materials: a review. Phytochem Anal. 2004;15:79–94. - PubMed
    1. Hazekamp A, Grotenhermen F. Review on Clinical Studies with Cannabis and Cannabinoids 2005-2009. Cannabinoids. 2010;5:1–21.

LinkOut - more resources